Chan Henry Lee's most recent trade in BeiGene Ltd - ADR was a trade of 56,953 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 56,953 | 131,976 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 50,037 | 134,758 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 300.19 per share. | 13 Aug 2025 | 6,052 | 2,178 (0%) | 0% | 300.2 | 1,816,724 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 13 Aug 2025 | 4,381 | 4,381 (0%) | 0% | 194.5 | 851,973 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 301.00 per share. | 13 Aug 2025 | 3,849 | 0 (0%) | 0% | 301.0 | 1,158,553 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 13 Aug 2025 | 3,849 | 8,230 (0%) | 0% | 159.0 | 612,106 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 13 Aug 2025 | 1,112 | 0 (0%) | 0% | 300 | 333,600 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 304.60 per share. | 30 Jul 2025 | 920 | 0 (0%) | 0% | 304.6 | 280,233 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 266.50 per share. | 16 Jun 2025 | 422 | 0 (0%) | 0% | 266.5 | 112,463 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 88,244 | 88,244 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 46,878 | 283,920 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 255.78 per share. | 06 Jun 2025 | 470 | 230 (0%) | 0% | 255.8 | 120,217 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 256.80 per share. | 06 Jun 2025 | 230 | 0 (0%) | 0% | 256.8 | 59,063 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 40,209 | 246,142 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 275.00 per share. | 27 Feb 2025 | 1,205 | 0 (0%) | 0% | 275 | 331,375 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 258.69 per share. | 21 Feb 2025 | 598 | 100 (0%) | 0% | 258.7 | 154,699 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 256.84 per share. | 21 Feb 2025 | 504 | 698 (0%) | 0% | 256.8 | 129,449 | American Depositary Shares |
| BeiGene Ltd - ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 260.22 per share. | 21 Feb 2025 | 100 | 0 (0%) | 0% | 260.2 | 26,022 | American Depositary Shares |
| BeiGene ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 237.10 per share. | 30 Sep 2024 | 1,202 | 0 (0%) | 0% | 237.1 | 284,994 | American Depositary Shares |
| BeiGene ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 160.57 per share. | 30 Jul 2024 | 834 | 0 (0%) | 0% | 160.6 | 133,915 | American Depositary Shares |
| BeiGene ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 159.68 per share. | 17 Jun 2024 | 208 | 129 (0%) | 0% | 159.7 | 33,213 | American Depositary Shares |
| BeiGene ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 159.74 per share. | 17 Jun 2024 | 129 | 0 (0%) | 0% | 159.7 | 20,606 | American Depositary Shares |
| BeiGene ADR | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 158.20 per share. | 17 Jun 2024 | 102 | 337 (0%) | 0% | 158.2 | 16,136 | American Depositary Shares |
| BeiGene ADR | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 184,795 | 184,795 | - | - | Share Option (Right to Buy) | |
| BeiGene ADR | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 98,085 | 269,399 (0%) | 0% | 0 | Ordinary Shares |